Advertisement

Topics

AMAG options exclusive worldwide rights to Velo's pre-eclampsia candidate

19:41 EDT 6 Jun 2017 | Elsevier Business Intelligence

Velo Bio LLC granted AMAG Pharmaceuticals Inc. an option to exclusive worldwide rights to its digoxin immune fab (DIF) pre-ec...

Original Article: AMAG options exclusive worldwide rights to Velo's pre-eclampsia candidate

NEXT ARTICLE

More From BioPortfolio on "AMAG options exclusive worldwide rights to Velo's pre-eclampsia candidate"

Quick Search
Advertisement